IPERLIPOPROTEINEMIE E DIABETE = HYPERLIPOPROTEINEMIES ET DIABETECREPALDI G; TIENGO A.1976; MINERVA, MED.; ITAL.; DA. 1976; VOL. 67; NO 4; PP. 290-300; BIBL. 48 REF.Article

CLINICAL ASPECTS OF HYPERLIPOPROTEINEMIACREPALDI G; FELLIN R.1974; ANN. BIOL. CLIN.; FR.; DA. 1974; VOL. 32; NO 4; PP. 309-322; BIBL. 37REF.Article

THE INFLUENCE OF PLASMA TRIGLYCERIDES ON HUMAN GROWTH HORMONE RESPONSE TO ARGININE AND INSULIN: A STUDY IN HYPERLIPEMICS AND NORMAL SUBJECTS. = INFLUENCE DES TRIGLYCERIDES PLASMATIQUES SUR LA REPONSE DE L'HORMONE SOMATOTROPE HUMAINE A L'ARGININE ET L'INSULINE: ETUDE CHEZ DES SUJETS HYPERLIPEMIQUES ET NORMAUXMUGGEO M; TIENGO A; FEDELE D et al.1975; HORMONE METABOL. RES.; GERM.; DA. 1975; VOL. 7; NO 5; PP. 367-374; BIBL. 1 P.Article

GROWTH HORMONE SECRETION IN PRIMARY ENDOGENOUS HYPERTRIGLYCERIDEMIA = SECRETION D'HORMONE SOMATOTROPE DANS L'HYPERTRIGLYCERIDEMIE PRIMAIRE ENDOGENEMUGGEO M; FEDELE D; TIENGO A et al.1973; HORMONE METABOL. RES.; GERM.; DA. 1973; VOL. 5; NO 3; PP. 224-225; BIBL. 5 REF.Article

Minibus électrique pour le centre historique de Trento = Electric minibus for Trento's historic centerCREPALDI, G.Véhicule électrique. Colloque. 1991, 15 p.Conference Paper

EFFECT OF PITUITARY ULTRASONIC TREATMENT ON PLASMA HUMAN GROWTH HORMONE LEVELS IN DIABETIC RETINOPATHY AND ACROMEGALY. = EFFET DU TRAITEMENT DE L'HYPOPHYSE PAR ULTRASONS SUR LE TAUX PLASMATIQUE D'HORMONE DE CROISSANCE DANS LA RETINOPATHIE DIABETIQUE ET L'ACROMEGALIE HUMAINEMUGGEO M; MOLINARI M; FEDELE D et al.1976; ACTA DIABETOL. LATINA; ITAL.; DA. 1976; VOL. 12; NO 2; PP. 137-149; BIBL. 1 P. 1/2Article

GLUCAGON SECRETION IN PRIMARY ENDOGENOUS HYPERTRIGLYCERIDEMIA BEFORE AND AFTER CLOFIBRATE TREATMENT. = SECRETION DE GLUCAGON DANS L'HYPERTRIGLYCERIDEMIE ENDOGENE PRIMAIRE AVANT ET APRES TRAITEMENT PAR CLOFIBRATETIENGO A; MUGGEO M; ASSAN R et al.1975; METABOLISM; U.S.A.; DA. 1975; VOL. 24; NO 8; PP. 901-914; BIBL. 1 P.Article

TERAPIA DELLE IPERLIPOPROTEINEMIE = THERAPEUTIQUE DES HYPERLIPOPROTEINEMIESCREPALDI G; FELLIN R; BRIANI G et al.1974; G. ITAL. CARDIOL.; ITAL.; DA. 1974; VOL. 4; NO 3; PP. 332-340; ABS. ANGL.; BIBL. 27 REF.Article

TRATTAMENTO DELLE IPERLIPIDEMIE PRIMITIVE CON UN TETRALIN-DERIVATO = TRAITEMENT DES HYPERLIPIDEMIES PRIMITIVES AU MOYEN D'UN DERIVE DE TETRALINEFELLIN R; FEDELE D; BAGNARIOL G et al.1972; G. ITAL. CARDIOL.; ITAL.; DA. 1972; VOL. 2; NO 6A; PP. 863-870; ABS. ANGL.; BIBL. 14 REF.Serial Issue

TRYPTOPHAN METABOLISM "VIA" NICOTINIC ACID IN PATIENTS WITH SCLERODERMA.DE ANTONI A; MUGGEO M; COSTA C et al.1976; ACTA VITAMINOL. ENZYMOL.; ITAL.; DA. 1976; VOL. 30; NO 4-6; PP. 134-139; ABS. ITAL.; BIBL. 14 REF.Article

PROCEEDINGS/OBESITY; PATHOGENESIS AND TREATMENT, SERONO SYMPOSIUM, ROME, JANUARY 1980ENZI G ED; CREPALDI G ED; POZZA G ED et al.1981; OBESITY: PATHOGENESIS AND TREATMENT. SYMPOSIUM/1980-01/ROME; GBR/USA/CAN; LONDON; NEW YORK; TORONTO: ACADEMIC PRESS; DA. 1981; 347 P.; 24 CM; ISBN 0-12-240150-6; PROCEEDINGS OF THE SERONO SYMPOSIA; 28Conference Proceedings

EFFECTS OF CLOFIBRATE TREATMENT ON ARGININE-INDUCED INSULIN SECRETION IN ENDOGENOUS HYPERTRIGLYCERIDEMIA.FEDELE D; TIENGO A; MUGGEO M et al.1976; ATHEROSCLEROSIS; NETHERL.; DA. 1976; VOL. 25; NO 2-3; PP. 191-198; BIBL. 1 P.Article

SHORT-TERM AND LONG-TERM CLINICAL EVALUATION OF A NON-AMPHETAMINE ANOREXIANT (MAZINDOL) IN THE TREATMENT OF OBESITY.ENZI G; BARITUSSIO A; MARCHIORI E et al.1976; J. INTERNATION. MED. RES.; G.B.; DA. 1976; VOL. 4; NO 5; PP. 305-318; BIBL. 20 REF.Article

INSULIN RECEPTOR ON MONOCYTES FROM PATIENTS WITH ACROMEGALY AND FASTING HYPERGLYCEMIAMUGGEO M; SAVIOLAKIS GA; BUSINARO V et al.1983; JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM; ISSN 0021-972X; USA; DA. 1983; VOL. 56; NO 4; PP. 733-738; BIBL. 14 REF.Article

MULTICENTER TRIAL WITH BEZAFIBRATE IN PRIMARY HYPERLIPIDEMIASFELLIN R; MARTINI S; CREPALDI G et al.1981; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1981; VOL. 29; NO 4; PP. 657-666; BIBL. 15 REF.Article

CHARACTERIZATION OF HYPERLIPIDEMIA IN TWO PATIENTS WITH ANALBUMINEMIABALDO G; FELLIN R; MANZATO E et al.1983; CLINICA CHIMICA ACTA; ISSN 0009-8981; NLD; DA. 1983; VOL. 128; NO 2-3; PP. 307-319; BIBL. 26 REF.Article

LONG-TERM TRIAL WITH COLESTIPOL PLUS CLOFIBRATE IN FAMILIAL HYPERCHOLESTEROLEMIA.FELLIN R; BAGGIO G; BRIANI G et al.1978; ATHEROSCLEROSIS; NETHERL.; DA. 1978; VOL. 29; NO 2; PP. 241-249; BIBL. 1 P. 1/2Article

LONG-TERM EFFECTS OF COLESTIPOL (U-26,597 A) ON PLASMA LIPIDS IN FAMILIAL TYPE II HYPERBETALIPOPROTEINAEMIA. = EFFETS A LONG TERME DU COLESTIPOL (U-26597 A) SUR LES LIPIDES DU PLASMA DANS L'HYPERBETALIPOPROTEINEMIE TYPE II FAMILIALEFELLIN R; BRIANI G; BALESTRIERI P et al.1975; ATHEROSCLEROSE; NETHERL.; DA. 1975; VOL. 22; NO 3; PP. 431-445; BIBL. 1 P.Article

BEZAFIBRATE AND CLOFIBRATE: EFFECTS ON PLASMA LIPIDS, LIPOPROTEINS AND APOPROTEINS COMPARED IN FAMILIAL HYPERCHOLESTEROLENIAMARTINI S; VALERIO G; FELLIN R et al.1982; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1982; VOL. 31; NO 3; SECT. 1; PP. 354-361; BIBL. 19 REF.Article

GLUCAGON AND INSULIN SECRETION IN POTENTIAL DIABETESTIENGO A; FEDELE D; MUGGEO M et al.1978; ACTA DIABETOL. LATINA; ITA; DA. 1978; VOL. 15; NO 3-4; PP. 143-151; BIBL. 21 REF.Article

ETUDE DE LA FONCTION HYPOPHYSO-THYROIDIENNE CHEZ DES PATIENTS HYPERLIPOPROTEINEMIQUES.BASCHIERI L; FELLIN R; MARTINO E et al.1975; REV. FR. ENDOCRINOL. CLIN.; FR.; DA. 1975; VOL. 16; NO 2-3; PP. 211-217; ABS. ANGL.; BIBL. 19 REF.; (PROBL. ACTUELS ENDOCRINOL. NUTR. PATHOL. METAB. XIVE JOURN. ENDOCRINOL. INT. PITIE; PARIS; 1975)Conference Paper

Dyslipoproteinemia in manifest diabetesMANZATO, E; CREPALDI, G.Journal of internal medicine. Supplement. 1994, Vol 236, Num 736, pp 27-31, issn 0955-7873Article

What therapy do our NIDDM patients need ? Insulin releasersCREPALDI, G; DEL PRATO, S.Diabetes research and clinical practice. 1995, Vol 28, Num AOU, pp S159-S165, issn 0168-8227, SUPConference Paper

Comparison of lipoprotein(a) assay methods in serum and in a plasminogen-free fractionBALDO-ENZI, G; BAIOCCHI, M. R; CREPALDI, G et al.Clinica chimica acta. 1993, Vol 218, Num 1, pp 83-95, issn 0009-8981Article

Glycosaminoglycans delay the progression of nephropathy in NIDDMSOLINI, A; VERGNANI, L; RICCI, F et al.Diabetes care. 1997, Vol 20, Num 5, pp 819-823, issn 0149-5992Article